Premium
The use of rituximab therapy in patients with acquired factor v inhibitors
Author(s) -
Navarrete M.A.,
van der Meer F.J.M.,
Damiani G.,
Diaz A.,
Eikenboom J.
Publication year - 2012
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23241
Subject(s) - medicine , rituximab , partial thromboplastin time , prothrombin time , factor vii , factor v , factor ix , gastroenterology , fibrinogen , methylprednisolone , thrombin time , fresh frozen plasma , surgery , immunology , antibody , coagulation , thrombosis , platelet
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom